Facebook
Twitter
LinkedIn
Forward
Ninth Annual Controversies in Hematologic Malignancies Symposium
This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include Hodgkin lymphoma, TKI's for CML, precision medicine, antifungal prophylaxis, cellular therapy for myeloma, updates in acute leukemia and more.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Pharmacists and Registered Nurses
Learning Objectives
The aim of this conference is to highlight major controversies in the treatment of hematological malignancies. At the completion of this activity, attendees will be able to make therapeutic decisions based on the available data, realizing the ongoing debate in those areas.
7:30-8:20am | Registration/Breakfast/View Exhibits
8:20-8:30am | Introduction
8:30-9:15am | CLL New Therapies
William G. Wierda, MD, PhD, MD Anderson Cancer Center
9:15-10:00am | Management of NHL in the Elderly
Nirav Shah, MD, Medical College of Wisconsin
10:00-10:15am | Break
10:15-11:00am | CARs/BiTEs in Hematologic Malignancies: Approved and Emerging Options
Parameswaran Hari, MD, MRCP, Medical College of Wisconsin
11:00-11:45am | Breakout Sessions
Measurement of Circulating Tumor DNA in Hematologic Malignancies
Timothy Fenske, MD, MS, Medical College of Wisconsin
Relevant Drug-Drug Interactions to Consider with Novel Oral Therapies
Lisa Samanas, PharmD
Cannabinoids and Cancer
Cecillia J. Hillard, PhD, Medical College of Wisconsin
11:45-12:45pm | Lunch
12:45-1:30pm | Updates in Smoldering Multiple Myeloma
Natalie Callander, MD, University of Wisconsin Health
1:30-2:15pm | Intensive vs. Less Intensive AML Therapy
Laura Michaelis, MD and Ehab Atallah, MD, Medical College of Wisconsin
2:15pm | Adjourn
Please ask for a complimentary parking ticket at the registration tables on the 5th floor of the Hilton in the Crystal Ballroom. A block of rooms has been reserved at a special rate (single or double occupancy) for the evening of Friday, February 28, 2020. The special room rate will be available under the group name "Medical College of Wisconsin - Hematology" until the group block is sold out.
Guest Speakers
Natalie Callander, MD
Professor of Medicine
Division of Hematology Oncology
University of Wisconsin School of Medicine and Public Health
William G. Wierda, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Froedtert and the Medical College of Wisconsin Speakers
Ehab Atallah, MD
Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Professor of Medicine
Parameswaran Hari, MD, MRCP
Professor of Medicine
Chief, Division of Hematology & Oncology
Medical College of Wisconsin
Cecilia Hillard, PhD
Associate Dean for Research
Director, Neuroscience Research Center
Medical College of Wisconsin
Laura Michaelis, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Nirav Shah, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Planning Committee
Sameem Abedin, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Lyndsey Runaas, MD
Co-Program Director
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
Dan Bullock
Education Program Coordinator
Division of Hematology and Oncology
Medical College of Wisconsin
Catherine Sestito, APNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin
Robert Taylor, MD
Director of Autologous Stem Cell Transplant Program
Aurora Cancer Care
Mindy Waggoner, PharmD, BCOP
Oncology Nurse Manager
Pharmacy-Oncology Services
Froedtert Hospital
All persons in control of content have NO relevant financial relationships to dislose with the exception of:
| Name | Company | Role |
|---|---|---|
| Nirav Shah, MD | Gilead-Kite Mitlenyi Biotech Celgene | Advisory Board Research/Advisory Board Advisory Board |
| Parameswaran Hari, MD | Bristol Myers Squibb, Janssen, Amgen, Karyopharm, Pharmacyclics, Abbvie | Consulting |
| Timothy Fenske, MD | Genentech. Adaptive Biotechnologies, AbbVie, Verastem, Kite MorphoSys Seattle Genetics, AstraZeneca,Celgene, Adaptive Biotechnologies Millennium, Kyowa. TG Therapeutics, Portola, Curis | Consultant Speaking Research Funding |
| William Wierda, MD, PhD | Novartis, AbbVie, Genentech, Pharmacyclics, Acerta Pharma, Gilead, Juno Therapeutics, KITE Pharma, Sunesis, Miragen, Oncternal Therapeutics, Cyclacel, Loxo Oncology, Janssen, Xencor | Research Funding |
| Cecilia Hillard, PhD | Phytecs, Inc. Beryl Therapeutics | Research Consulting |
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 5.25 hours of participation for continuing education for allied health professionals.
Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930. This program has been approved for 5.25 contact hours of continuing education (which includes 0.75 hours of pharmacology).
Available Credit
- 5.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 5.25 Hours of ParticipationHours of Participation credit.
- 0.75 NP PharmacologyNP Pharmacology credit.
- 5.25 NP Contact Hours